Biomerica (BMRA) Return on Capital Employed Growth (3y) (2014 - 2026)
Biomerica (BMRA) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.00 Bn | 175.71 Bn | 6.27 Bn | -1,679.00 |
| 2 | Stryker | 128.69 Bn | 125.81 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 68.39 Bn | 66.93 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 47.97 Bn | 44.30 Bn | 1.29 Bn | -846.00 |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.00 Bn | 1.98 Bn | -247.00 |
| 7 | Dexcom | 28.21 Bn | 27.09 Bn | 750.30 Mn | 1,318.00 |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | - |
| 10 | Biomerica | 4.88 Mn | 3.54 Mn | -44,000.00 | -4,422.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -4,422.00 |
| Nov 30, 2025 | -4,442.00 |
| Aug 31, 2025 | -5,023.00 |
| May 31, 2025 | -6,796.00 |
| Feb 28, 2025 | -4,240.00 |
| Nov 30, 2024 | -2,552.00 |
| Aug 31, 2024 | -3,134.00 |
| May 31, 2024 | -1,739.00 |
| Feb 29, 2024 | -2,083.00 |
| Nov 30, 2023 | -1,890.00 |
| Aug 31, 2023 | -2,486.00 |
| May 31, 2023 | -5,261.00 |
| Feb 28, 2023 | -4,635.00 |
| Nov 30, 2022 | -1,378.00 |
| Aug 31, 2022 | -10.00 |
| May 31, 2022 | 2,559.00 |
| Feb 28, 2022 | 800.00 |
| Nov 30, 2021 | -3,174.00 |
| Aug 31, 2021 | -2,988.00 |
| Aug 31, 2020 | -226.00 |